M And A
Aurora Cannabis Rejects Curaleaf's Acquisition Claims, Tells Shareholders to Wait
The Canadian producer disputes the U.S. operator's public statements about a takeover approach and urges investors not to act prematurely.
Aurora Cannabis is publicly pushing back against Curaleaf's claims regarding the American company's efforts to acquire the Canadian licensed producer. Aurora is urging its shareholders to wait before responding to any overtures, signaling a contentious start to the unsolicited approach.
Aurora Cannabis has issued a direct rebuttal to U.S. cannabis company Curaleaf following the American operator's public statements about its attempt to acquire the Canadian producer. The response marks a sharp escalation in what appears to be an unsolicited takeover effort.
In its message, Aurora is urging shareholders to hold off on taking any action related to Curaleaf's approach. The company's leadership is disputing the claims made by Curaleaf, though specific details of the disagreement were not outlined in the initial report.
The dispute pits one of Canada's most prominent licensed producers against a major U.S. multi-state operator, highlighting the ongoing cross-border tensions and consolidation pressures within the global cannabis industry.